Browse by People

Collapse authors list.
Almutairi, Mubarak, Lister, Adam ORCID: 0000-0003-4085-6367, Zhao, Qing, Line, James ORCID: 0000-0003-3568-8928, Adair, Kareena ORCID: 0000-0001-9884-2094, Tailor, Arun, Waddington, James ORCID: 0000-0003-2641-5055, Clarke, Elsie ORCID: 0000-0002-5913-0606, Gardner, Joshua ORCID: 0000-0002-4520-108X, Thomson, Paul ORCID: 0000-0001-5431-0459 et al (show 10 more authors) , Harper, Nicolas, Sun, Yonghu, Sun, Lele, Ostrov, David A ORCID: 0000-0002-4696-875X, Liu, Hong, MacEwan, David J ORCID: 0000-0002-2879-0935, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Meng, Xiaoli ORCID: 0000-0002-7774-2075, Zhang, Furen and Naisbitt, Dean J (2023) Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides. Journal of immunology (Baltimore, Md. : 1950), 210 (8). pp. 1031-1042.

Gardner, Joshua, Ogese, Monday ORCID: 0000-0002-1873-4032, Betts, Catherine J, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Naisbitt, Dean J (2022) Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01. Chemical research in toxicology, 35 (2). pp. 199-202.

Collapse authors list.
Hammond, Sean, Olsson-Brown, Anna, Grice, Sophie, Gibson, Andrew, Gardner, Joshua, Castrejon-Flores, Jose Luis, Jolly, Carol, Fisher, Benjamin Alexis, Steven, Neil, Betts, Catherine et al (show 3 more authors) , Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Meng, Xiaoli ORCID: 0000-0002-7774-2075 and Naisbitt, Dean John (2022) Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. TOXICOLOGICAL SCIENCES, 186 (1). pp. 58-69.

Gardner, Joshua (2022) DETERMINING THE IMMUNOGENICITY OF GLYCOPEPTIDE ANTIBIOTICS IMPLICATED IN DRUG HYPERSENSITIVITY REACTIONS. PhD thesis, University of Liverpool.

Ogese, Monday O ORCID: 0000-0002-1873-4032, Lister, Adam, Gardner, Joshua, Meng, Xiaoli ORCID: 0000-0002-7774-2075, Alfirevic, Ana ORCID: 0000-0002-2801-9817, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Park, B Kevin ORCID: 0000-0001-8384-824X and Naisbitt, Dean J (2021) Deciphering Adverse Drug Reactions: <i>In Vitro</i> Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01. TOXICOLOGICAL SCIENCES, 183 (1). pp. 139-153.

Collapse authors list.
Gardner, Joshua ORCID: 0000-0002-4520-108X, Hammond, Sean, Jensen, Rebecca ORCID: 0000-0003-1134-2869, Gibson, Andrew, Krantz, Matthew S, Ardern-Jones, Michael, Phillips, Elizabeth J, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Chadwick, Amy E, Betts, Catherine et al (show 1 more authors) and Naisbitt, Dean J (2024) Glycolysis: An early marker for vancomycin-specific T-cell activation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Collapse authors list.
Gardner, Joshua ORCID: 0000-0002-4520-108X, Hammond, Sean, Jensen, Rebecca ORCID: 0000-0003-1134-2869, Gibson, Andrew, Krantz, Matthew S, Ardern-Jones, Michael, Phillips, Elizabeth J, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Chadwick, Amy E, Betts, Catherine et al (show 1 more authors) and Naisbitt, Dean J (2024) Glycolysis: An early marker for vancomycin-specific T-cell activation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 54 (1). pp. 21-33.

Collapse authors list.
Ogbe, Ane, Kronsteiner, Barbara, Skelly, Donal T, Pace, Matthew, Brown, Anthony, Adland, Emily, Adair, Kareena ORCID: 0000-0001-9884-2094, Akhter, Hossain Delowar, Ali, Mohammad, Ali, Serat-E ORCID: 0000-0002-9806-8796 et al (show 70 more authors) , Angyal, Adrienn, Ansari, M Azim, Arancibia-Carcamo, Carolina V, Brown, Helen, Chinnakannan, Senthil, Conlon, Christopher, de Lara, Catherine, de Silva, Thushan, Dold, Christina, Dong, Tao, Donnison, Timothy, Eyre, David, Flaxman, Amy, Fletcher, Helen, Gardner, Joshua, Grist, James T, Hackstein, Carl-Philipp, Jaruthamsophon, Kanoot ORCID: 0000-0003-1563-0024, Jeffery, Katie, Lambe, Teresa, Lee, Lian, Li, Wenqin, Lim, Nicholas, Matthews, Philippa C, Mentzer, Alexander J, Moore, Shona C ORCID: 0000-0001-8610-2806, Naisbitt, Dean J, Ogese, Monday ORCID: 0000-0002-1873-4032, Ogg, Graham, Openshaw, Peter, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, Pollard, Andrew J, Ramamurthy, Narayan, Rongkard, Patpong, Rowland-Jones, Sarah, Sampson, Oliver, Screaton, Gavin, Sette, Alessandro, Stafford, Lizzie, Thompson, Craig, Thomson, Paul J ORCID: 0000-0001-5431-0459, Thwaites, Ryan, Vieira, Vinicius, Weiskopf, Daniela, Zacharopoulou, Panagiota, Chalk, Jeremy, Kerr, Georgina, Phalora, Prabhjeet, Csala, Anna, Jones, Mathew, Robinson, Nicola, Brown, Rachael, Hutchings, Claire, Provine, Nicholas, Ratcliff, Jeremy, Amini, Ali, Borak, Martyna, Dimitriadis, Stavros, Fordwoh, Thomas, Horsington, Bryn, Johnson, Sile, Morrow, Jordan, Warren, Yolanda, Wells, Charlie, Turtle, Lance ORCID: 0000-0002-0778-1693, Klenerman, Paul, Goulder, Philip, Frater, John, Barnes, Eleanor and Dunachie, Susanna (2021) T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. NATURE COMMUNICATIONS, 12 (1). 2055-.

Hammond, Sean, Olsson-Brown, Anna, Gardner, Joshua, Thomson, Paul ORCID: 0000-0001-5431-0459, Ali, Serat-E ORCID: 0000-0002-9806-8796, Jolly, Carol, Carr, Dan, Ressel, Lorenzo ORCID: 0000-0002-6614-1223, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 and Naisbitt, Dean (2021) T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9 (5). e002521-.

Collapse authors list.
Ogese, Monday O ORCID: 0000-0002-1873-4032, Lister, Adam, Farrell, Liam, Gardner, Joshua, Kafu, Laila, Ali, Serat-E, Gibson, Andrew, Hillegas, Aimee, Meng, Xiaoli ORCID: 0000-0002-7774-2075, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 et al (show 3 more authors) , Williams, Geoffrey S, Sakatis, Melanie Z and Naisbitt, Dean J (2023) A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment. TOXICOLOGICAL SCIENCES, 197 (1). pp. 38-52.